Adiso Therapeutics
PrivateLast Round
Series A
Mar 10, 2022
Total Funding Raised
$60M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Adiso Therapeutics is a biotechnology company that develops novel therapeutics to treat inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Adiso Therapeutics Comparables
Compare Adiso Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Allianthera (Suzhou) Biopharmaceuticals Co., Ltd. | 81% | |
| Cibus Therapeutics | 80% | |
| Olatec Therapeutics | 80% | |
Adiso Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Mar 10, 2022 |
Adiso Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Morningside Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Grew 27% QoQ from 11 to 14 employees.
- May 13, 2026
Monthly visitors grew 299% MoM, from 223 to 889.
Adiso Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Adiso Therapeutics's valuation, stock price, and market status.